Home MarketAlbert David Ltd.

Albert David Ltd. Stock Info: As on 2018-02-23 15:40:01

Nse

365.10

-0.10(-0.03%)
Change%
52 Week Range
275.00
30.00
498.00
12.00
Open362.00
Day's Range346.94 - 383.46
Value Traded (in ₹ Cr.) 0.07

Bse

370.00

4.30(1.18%)
Change %
52 Week Range
276.00
15.00
497.00
12.00
Open365.00
Day's Range347.42 - 383.99
Value Traded (in ₹ Cr.) 0.02

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 3,475,514.00 60.90%
Mutual Funds/UTI 900.00 0.02%
FII 0.00 0.00%
Employee 0.00 0.00%
Public 1,652,359.00 28.95%
Government 0.00 0.00%
Others 316,240.00 5.54%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 0.52
Basic EPS (Rs.) 84.10
Cash EPS 99.86
BVPerShare Excl 239.75
Operating Revenue 564.53
PBDITPerShare 57.86
Dividend 5.50
NPPerShare 84.10
Current Ratio 2.01
Quick Ratio 1.37
PriceToBV 1.25
Earnings 0.28
PBDIT Margin 10.24
PBT Margin 19.55
NP Margin 14.89
Return On Assets 21.44
Retention Ratios 93.45
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 324.16
Total Expenses 301.94
EBITDA 33.02
PBT 63.02
PAT 48.00
Net Income 48.00
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 143.76
Total Expenses 136.50
EBITDA 2.69
PBT 47.32
PAT 38.83
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 5.71
Net worth 136.83
Investments 47.54
Total Liability 223.84
Total debt 20.23
Net block 49.45
Total Assets 223.84
Parameter Sep-16 (₹ Cr.) 6M % change
Total share capital 5.71
Net worth 102.01
Investments 16.50
Total Liability 198.80
Total debt 21.19
Net block 51.38
Total Assets 198.80
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

613.15 607 1.01
603.6668.8

Abbott India Ltd.

5811.3 5754.4 0.99
5470.056125

Ajanta Pharma Ltd.

1374.45 1350.3 1.79
1311.31420

Alembic Ltd.

61.1 60.8 0.49
60.363.45

Alembic Pharmaceuticals Ltd.

561.9 563.7 -0.32
546.8585

Alkem Laboratories Ltd.

2181.3 2174.8 0.3
2115.12185

Alpa Laboratories Ltd.

43.75 41.7 4.92
38.346.6
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

50.1 49.35 1.52
48.7554.15

Aarti Drugs Ltd.

608.05 607.05 0.16
602.6680

Aayush Food & Herbs Ltd.

63.6 63.5 0.16
59.166.9

Abbott India Ltd.

5788.4 5746.8 0.72
5445.355950

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23
0.30.3
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities 68.21
Cash from investing activities -38.34
Cash from financing activities -17.93
Net change in cash 11.95

Stock Held By Mutual Fund Schemes

ABC India posts Q3 net loss of Rs 2.25 cr

The company reported standalone net loss during the quarter stood at Rs 2.25 crore as compared to net loss of Rs 13.70 crore in the previous year quarter. Net revenue of the company declined moderately by 12.76 per cent at Rs 28.45 crore in October-December quarter of this fiscal as against Rs 32.61 crore in the corresponding period last year. During October-December quarter, operating expenses dropped by 33.09 per cent to Rs 29.90 crore from Rs 44.69 crore in year ago period. Other Income grew by 400.00 per cent at Rs 0.05 crore versus (Dec'16 Rs 0.01 crore). Operating Profit slipped by 87.88 per cent to Rs -1.46 crore as against Rs -12.05 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 86.14 per cent in December quarter. Interest declined by 10.78 per cent y-o-y to Rs 0.91 crore, while Taxation decreased by 40.00 per cent at Rs -0.03 crore (Dec'16 Rs -0.05 crore).

23-02-2018 15:37

Zenith Exports L posts Q3 net loss of Rs 1.49 cr

The company reported standalone net loss during the quarter stood at Rs 1.49 crore compared to net profit of Rs 0.51 crore in the previous year quarter. Net revenue of the company declined moderately by 17.19 per cent at Rs 21.87 crore in October-December quarter of this fiscal as against Rs 26.41 crore in the corresponding period last year. During October-December quarter, operating expenses dropped by 19.87 per cent to Rs 22.46 crore from Rs 28.03 crore in year ago period. Other Income dipped by 14.81 per cent at Rs 0.23 crore versus (Dec'16 Rs 0.27 crore). Operating Profit slipped by 171.95 per cent to Rs -0.59 crore as against Rs 0.82 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 187.10 per cent in December quarter. Interest grew by 320.00 per cent y-o-y to Rs 0.21 crore, while Taxation increased by 42.86 per cent at Rs 0.30 crore (Dec'16 Rs 0.21 crore).

23-02-2018 15:37

Austin Engg. Co. posts Q3 net loss of Rs 0.70 cr

The company reported standalone net loss during the quarter stood at Rs 0.70 crore as compared to net loss of Rs 0.83 crore in the previous year quarter. Net revenue of the company declined moderately by 9.59 per cent at Rs 16.02 crore in October-December quarter of this fiscal as against Rs 17.72 crore in the corresponding period last year. During October-December quarter, operating expenses dropped by 11.67 per cent to Rs 16.42 crore from Rs 18.59 crore in year ago period. Other Income dipped by 92.00 per cent at Rs 0.02 crore versus (Dec'16 Rs 0.25 crore). Operating Profit slipped by 40.00 per cent to Rs -0.39 crore as against Rs -0.65 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 33.60 per cent in December quarter. Interest declined by 33.33 per cent y-o-y to Rs 0.14 crore, while Taxation increased by 25.00 per cent at Rs -0.10 crore (Dec'16 Rs -0.08 crore).

23-02-2018 15:37

Dhoot Industrial Q3 net profit zooms 264.91% at Rs 2.08 cr

The company reported standalone net profit of Rs 2.08 crore for the quarter ended December 31, 2017 as compared to Rs 0.57 crore in the same period last year, registering a year-on-year growth of 264.91 per cent. Net revenue of the company rose moderately by 8.18 per cent at Rs 18.25 crore in October-December quarter of this fiscal as against Rs 16.87 crore in the corresponding period last year. During October-December quarter, operating expenses dropped by 5.41 per cent to Rs 16.26 crore from Rs 17.19 crore in year ago period. Other Income grew by 6.71 per cent at Rs 1.75 crore versus (Dec'16 Rs 1.64 crore). Operating Profit surged by 123.60 per cent to Rs 1.99 crore as against Rs 0.89 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 107.62 per cent in December quarter. Interest declined by 38.46 per cent y-o-y to Rs 0.64 crore, while Taxation increased by 18.31 per cent at Rs 0.84 crore (Dec'16 Rs 0.71 crore).

23-02-2018 15:37

ITL Industries Q3 net profit jumps 65.85% at Rs 1.36 cr

The company reported standalone net profit of Rs 1.36 crore for the quarter ended December 31, 2017 as compared to Rs 0.82 crore in the same period last year, registering a year-on-year growth of 65.85 per cent. Net revenue of the company rose moderately by 16.94 per cent at Rs 20.30 crore in October-December quarter of this fiscal as against Rs 17.36 crore in the corresponding period last year. During October-December quarter, operating expenses increased by 17.41 per cent to Rs 18.34 crore from Rs 15.62 crore in year ago period. Other Income grew by 1600.00 per cent at Rs 0.17 crore versus (Dec'16 Rs 0.01 crore). Operating Profit surged by 12.64 per cent to Rs 1.96 crore as against Rs 1.74 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 3.50 per cent in December quarter. Interest declined by 49.02 per cent y-o-y to Rs 0.26 crore, while Taxation increased by 100.00 per cent at Rs 0.28 crore (Dec'16 Rs 0.14 crore).

23-02-2018 15:37

Albert David Ltd - Results For Quarter & Nine Months Ended 31St December, 2017

The Results for Quarter & Nine Months ended 31st December, 2017 as submitted by us vide Announcement ID 265492 at 14:58:30 is enclosed in machine readable/ searchable pdf format for your records.

12-Feb-2018 04:31 PM

Albert David Ltd - Outcome of Board Meeting

Albert David Limited has informed the Exchange regarding Outcome of Board Meeting held on February 12, 2018.

12-Feb-2018 03:33 PM

Albert David Ltd - Financial Result Updates

Albert David Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.

12-Feb-2018 03:03 PM

Albert David Ltd - Un-Audited Financial Results For The Quarter & Nine Months Ended 31St December, 2017

The Board of Directors in its meeting held today, inter-alia, considered and approved the Un-audited Financial Results of the Company for the Quarter and Nine months ended 31st December, 2017.

In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a copy of the said Statement of Unaudited Financial Results for the Quarter and Nine Months ended 31st December, 2017 and Limited Review Report issued by M/s. Basu Chanchani & Deb, Chartered Accountants, Statutory Auditors of the Company is enclosed herewith.

The Board Meeting commenced at 11.00 a.m. and concluded at 2.50 p.m..

Please take the same on record.

12-Feb-2018 02:59 PM

Albert David Ltd - Trading Window

Albert David Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

01-Feb-2018 11:30 AM

Albert David Ltd - Results For Quarter & Nine Months Ended 31St December, 2017

The Results for Quarter & Nine Months ended 31st December, 2017 as submitted by us vide Announcement ID 265492 at 14:58:30 is enclosed in machine readable/ searchable pdf format for your records.

12-Feb-2018 04:31 PM

Albert David Ltd - Un-Audited Financial Results For The Quarter & Nine Months Ended 31St December, 2017

The Board of Directors in its meeting held today, inter-alia, considered and approved the Un-audited Financial Results of the Company for the Quarter and Nine months ended 31st December, 2017.

In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a copy of the said Statement of Unaudited Financial Results for the Quarter and Nine Months ended 31st December, 2017 and Limited Review Report issued by M/s. Basu Chanchani & Deb, Chartered Accountants, Statutory Auditors of the Company is enclosed herewith.

The Board Meeting commenced at 11.00 a.m. and concluded at 2.50 p.m..

Please take the same on record.

12-Feb-2018 02:59 PM

Albert David Ltd - Board Meeting On 12/02/2018

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a Meeting of Board of Directors of the Company will be held on 12th February, 2018 to consider and approve the Un-audited Financial Results of the Company for the Quarter and Nine months ended 31st December, 2017.

In view of the aforesaid Board meeting and in terms of the Company's Code of Conduct for Prohibition of Insider Trading, 'Trading Window' of the Company shall remain closed from Friday, 2nd February, 2018 to Wednesday, 14th February, 2018 (both days inclusive).

This is for your information and record.

01-Feb-2018 11:03 AM

Corporate Details

About Management

The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.

Registered Office

D - Block, 3rd Floor, Gillander House, Netaji Subhas Road,

033-22302330,22628436,22628456-8492,      033-22258714,

adidavid@dataone.in

http://www.albertdavidindia.com

Registrar Details

Maheshwari Datamatics (P) Ltd.